Consensus Wang Maolu: Under the epidemic, how to use the blockchain to solve the problem of drug shortage?

-PART1-

Lead

A sudden outbreak of a new coronavirus, which opened in 2020, gave each of us a head start, and the whole society was forced to press the pause button.

Many SME entrepreneurs are filled with fear, anxiety, powerlessness, helplessness, and even some entrepreneurs pessimistically think, "Maybe you and I will be bankrupted for a month or two."

As everyone knows, "Every crisis is a blessing", every crisis has hidden opportunities. The greater the crisis, the greater the chance!

In 2003, physical stores upgraded e-commerce due to SARS;

In 2020, the centralized office will be distributed and coordinated due to the new crown epidemic situation;

Blockchain business value and rules such as remote collaboration, open source governance, token incentives, autonomous organizations, distributed commerce, and distributed office have brought new opportunities to business organizations.

In this special column, 13 blockchain industry talent think tank experts will share online themes and systematically output daily reflections and suggestions in a specific field to inspire and inspire SMEs and business organizations caught in the epidemic crisis. stand by! Get 13 free live lessons for everyone!

The guidance unit for this column is the Blockchain Industry Talent Research Institute of the Talent Exchange Center of the Ministry of Industry and Information Technology, which is sponsored by the Blockchain Industry Talent Think Tank, Huoxun Finance, and Chainman International.

The Blockchain Industry Talent Think Tank is jointly initiated by the Blockchain Industry Talent Research Institute of the Ministry of Industry and Information Technology, the Blockchain Industry Talent Research Institute, Tsinghua x-lab, Securities Daily, the Fujian Blockchain Association, and Huoxun Finance To gather experts from various fields to build an open ecosystem that is coordinated with the government-industry-industrial-research application of the blockchain.

On the evening of February 5th, Wang Maolu, Chairman of Consensus Shuxin, was a guest at Fire News TALK. The following is a record of the interview.

-PART2-

Highlights

Wang Maolu, Chairman of Consensus Shuxin:

  • The blockchain is linked to the B-side business and data resources. Studying the landing scenarios of the blockchain and industry and industry is the top priority.
  • Regarding the technical direction of the blockchain industry, we believe that it mainly addresses performance, scalability, the security of the chain itself, high availability, and large file storage.
  • Difficult medical data sharing makes it difficult to carry out hierarchical diagnosis and treatment
  • Hierarchical diagnosis and treatment system based on blockchain can be applied to multiple fields
  • This epidemic also has a prominent problem in the management of the shortage of drugs, which involves manufacturers, development reforms, drug supervision, and hospital information collection.
  • Use blockchain to synchronize data at the point-to-point level and solve the problem of drug shortage

-PART3-

Interview Record

Moderator Zhao Yidan, editor-in-chief of Huoxun Finance: Thank you for watching the special section of the blockchain industry talent think tank of Huoxun TALK! The theme of this special column is "How does blockchain help business and organizational innovation under the epidemic?"

The next guest to play is Wang Maolu, chairman of Consensus Shuxin.

Wang Maolu

Ph.D. in Electronic Engineering from Beijing University of Aeronautics and Astronautics, founder of Beijing Consensus Digital Technology Co., Ltd., concurrently serves as the deputy director of the Blockchain Lab of China Information Technology Promotion Alliance, a member of the Information Committee of the China Listed Companies Association, and a former member of the National Financial Standardization Committee.

Now engaged in the application practice of blockchain and AI technology, he has presided over the design and implementation of blockchain projects of China Insurance Information Technology Corporation, the State Food and Drug Administration, and CITIC Group. He has conducted in-depth research on the application of blockchain in the field of copyright and participated in the technical realization of the nation's first blockchain intellectual property jurisprudence.

Wang Maolu: Hello, many old friends in the group. Today I will share with you some of the blockchain cases we have done at the National Health Commission and the State Drug Administration.

Zhao Yidan: The theme that President Wang shared tonight is "Exploration in the Supervision of Drug Intelligence", and I look forward to the wonderful sharing of President Wang!

01

The blockchain is linked to the B-side business and data resources. Researching the blockchain and industry and industry landing scenarios is the top priority.

Wang Maolu: First of all, I would like to introduce our Beijing Consensus Co., Ltd., which mainly provides blockchain + big data products and services to large enterprise groups and government agencies. The company is committed to interconnecting and interconnecting industrial chains through the assumption of alliance chains, and using blockchain + big data technology to improve the efficiency and value of data circulation inside and outside the industry, and gradually build a new type of industrial interconnection and digital ecology.

My understanding is that the blockchain is linked to the B-side business and data resources, and a new type of digital ecology is gradually built through the trust mechanism.

Zhang Xiaoyuan: Use the blockchain service B-side to achieve more efficient data applications.

Wang Maolu: Yes. At present, large-scale C-side application scenarios have not yet appeared, and research on the implementation scenarios of blockchain and industry and industry is the top priority.

This is a number of scientific research topics that we have undertaken since its establishment, as well as the continuous development and improvement of the blockchain from an idea to a solution and tool.

This is the product platform and tools we continue to provide in the blockchain. At present, the products include CoBaaS platform, blockchain data adapter, large file slicing and on-chain system, TOKEN management system, judicial depositary union public chain, and area for data sharing and exchange Blockchain exchange platform, a lightweight software and hardware integrated module for the power internet of things.

Regarding the technical tackling direction of the blockchain industry, we believe that it mainly addresses performance, scalability, security of the chain itself, high availability, and large file storage. In the medical industry, we have undertaken a task of the National Health and Medical Commission to work with the Fujian Union Hospital to solve the medical record sharing and collaboration issues of the medical consortium. Medical data sharing is difficult, which makes it difficult to carry out hierarchical diagnosis and treatment.

Zhang Xiaoyuan: A national task, bearing a great mission.

Wang Maolu: There are issues such as internal data governance in the medical and health industry that has not completed privacy protection.

Our approach is to construct the data into a loosely coupled alliance chain. The data itself is not on the chain. The chain completes the data directory connection, identity, and business request authentication. Therefore, the time is based on referral, data sharing of consultation business, and can Private key isolation and data encryption transmission are performed to achieve business traceability and assessment.

This is a referral process.

The hierarchical diagnosis and treatment system based on the blockchain can be applied to multiple fields.

Community medical treatment, admission to the nearest hospital, special treatment, cross-domain diagnosis and treatment. What I have shared above is the pilot situation of the Health and Medical Commission.

We also undertook a subject at the State Drug Administration, which is to use the blockchain to solve the supervision of drug variety files and technological processes. Everyone remembers the vaccine incident.

On July 23, 2018, an important instruction was given to the case of Changchun Changsheng Biovaccine in Jilin: Changchun Changsheng Biotechnology Co., Ltd.'s illegal and illegal production of vaccines was harsh in nature and shocking. Relevant localities and departments should attach great importance to the investigation of the facts immediately, to the end, serious accountability and strict handling according to law. It is necessary to announce the progress of the investigation in a timely manner and effectively respond to the concerns of the masses.

The essence is how to supervise the production of medicines. In fact, there are many difficulties.

Our idea is to build an industry chain, and each role will be linked to the corresponding information:

The respective roles and tasks are shown in the figure above, in production and logistics.

In the end, a supervision and coordination chain involving all parties in the industry was constructed to satisfy the multi-party collaboration ecology of pharmaceutical companies, regulators, users, and the public.

02

Use blockchain to synchronize data at the point-to-point level and solve the problem of drug shortage

Wang Maolu: In fact, there is another outstanding problem in this epidemic situation, which is the management of the shortage of medicines. The shortage of medicines is a very complicated issue.

Zhang Xiaoyuan: Yes, there is a serious shortage of medical supplies and medicines

Zhao Yidan: How can we improve this problem?

Wang Maolu: Involving manufacturers, development and reform, drug supervision, and hospital information collection from multiple departments and links.

There are now more than 4,000 pharmaceutical companies in China. On the surface, there are a large number of pharmaceutical manufacturers in China, and the overall supply of drugs exceeds supply. On the surface of the oversupply, there are still some companies that are unwilling to produce, or in short supply of, drugs that are in short supply.

For example, masks are in short supply when an epidemic comes, and excess supplies when there is no epidemic.

  • Shortage of cheap medicines: Good medicines with good curative effects are nowhere to be purchased. These medicines have alternatives, but the prices are high.
  • Shortage of special-effect medicines: There is a shortage of clinically necessary rescue medicines. Such medicines must be used and there is no substitute.
  • Shortage of special medicines: due to the small amount of medicines, the production and reserves are insufficient;
  • The shortage of medicines caused by emergencies. After the emergencies, these medicines were inadequate or inadequate in emergency plans, which prevented hospitals from buying the medicines they needed.

What are the difficulties in management?

Zhang Xiaoyuan: Yes, how can you be fully prepared but not left over?

Wang Maolu: The total amount of medicine is small, the management cost is high, and the profit is small, especially the orphan medicine and some poison rescue drugs, the enterprise is unwilling to produce;

Tight supply of raw materials leads to shortage of medicines;

Pharmaceutical distribution companies have no profit or low profit, and are unwilling to operate;

No business between the hospital and the supplier;

Drug bidding may lead to low drug prices or even upside-down prices, leading to regional drug shortages.

One idea is to use the blockchain to achieve point-to-point-level data synchronization. First, for the production plan of pharmaceutical companies, in response to the shortage of market-oriented drugs, provide relevant data and subsidies to encourage pharmaceutical companies to immediately produce shortages of drugs.

Aiming at the research and development arrangements of new drugs, and in response to the shortage of market-oriented drugs, analysis of the types of shortages is provided to assist pharmaceutical companies to adjust the research and development direction of new drugs.

Regarding the allocation of medicines, in view of the shortage of regional medicines, relevant data is provided to support medical institutions in allocating and sharing medicine resources with each other to solve the shortage.

Regarding the targeted sales of medicines and the shortage of regional medicines, provide relevant data to support the targeted marketing of pharmaceutical companies and solve the shortage.

Realize information collection synchronization, trusted computing, production allocation incentives through the chain, and settle down several major databases such as industry libraries, production libraries, inventory libraries, research and development libraries, etc., to further mine the data and generate statistical prediction models to further guide production scheduling Perform warnings and forecasts.

Probably share this with everyone.

In fact, the application in the pharmaceutical industry is still very broad. Blockchain is not only a technology but also a brand new trust mechanism and governance tool. I hope to promote exploration with colleagues.

Zhao Yidan: President Wang shared with us how the blockchain can solve the problem of medical records sharing and collaboration of the medical consortium, how to solve the drug variety file and process supervision, and how to solve the problem of drug shortage. The case is very detailed!